ArticleOncotarget2014

The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer.

Martin C Sadowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.